2023 Networking Pharma Pharmaceutical manufacturing 
European Pharmaceutical Review
OCTOBER 12, 2023
September 2023 saw a wave of new pharmaceutical manufacturing facility expansions and launches across Europe. Research by the Confederation of British Industry (CBI) , released in September this year, highlighted progress for UK manufacturing in its latest Industrial Trends Survey. Kerry, Ireland.
European Pharmaceutical Review
SEPTEMBER 28, 2023
There has been a steady stream of developments in the vaccine manufacturing space throughout 2023. A notable milestone was Moderna’s announcement in April that it had, following finalisation of a ten-year strategic partnership with the UK Government, commenced construction of its mRNA vaccine manufacturing technology centre.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
European Pharmaceutical Review
JULY 21, 2023
Recent guidance published by the European Medicines Agency outlines measures that will be taken to increase preparedness for the autumn/winter 2023-2024. Recommendations were also published earlier this year for all stakeholders in the pharma supply chain. Globalisation and supply chain complexity are a factor.
pharmaphorum
DECEMBER 16, 2022
Of significant interest to the pharma industry are the suggestions in the draft text that money granted for research on infectious diseases could include specifications on how eventual products could be marketed. The next official step will be to deliver a progress report to the 76th World Health Assembly in 2023, which will convene in May.
Clarify Health
OCTOBER 26, 2021
In this blog, we take a close look at health equity in oncology trials specifically, assessing how the lack of diversity and inclusion has impacted cancer patients and the pharma industry’s key initiatives to address it. J National Comprehensive Cancer Network. 1] Zaorsky NG, Zhang Y, Walter V, Tchelebi LT, Chinchilli VM, Gusani NJ.
PM360
AUGUST 9, 2022
Pharma Manufacturer Solutions. GM of Manufacturer Solutions. 1 GoodRx’s partnerships with pharma manufacturers and other key stakeholders in the healthcare industry enable them to offer discounts which have helped patients fill at least 80 million prescriptions that they otherwise could not afford. Patty Riskind.
Impetus Digital
NOVEMBER 23, 2023
With the end of the year quickly approaching, you will likely see multiple articles on the key trends of 2023 and predictions for 2024 start popping up. Many of these will discuss the expanding role and capabilities of AI and machine learning in the Pharma space. Others want to have access to information on demand, at their fingertips.
Expert insights. Personalized for you.
84 
Let's personalize your content